Menu Close
The Conversation

Anna Cranston

1

Article

0

Comments
Postdoctoral Research Fellow, University of Aberdeen

Anna graduated in June 2015 with a first class BSc (Hons) in Pharmacology from the University of Aberdeen. She joined biotechnology company TauRx Therapeutics Ltd (University of Aberdeen) in October 2015 as a PhD student. Her project investigated synaptic alterations and neuroinflammation observed within transgenic models of Alzheimer's Disease and Tauopathy. In 2019 she joined the Krembil Research Institute at Toronto Western Hospital as a postdoctoral research fellow.

Experience

  • 2019–present
    Postdoctoral research fellow, University Health Network (Toronto)
  • 2015–2019
    PhD Student, University of Aberdeen

Publications

  • 2020
    Mechanisms of Anticholinesterase Interference with Tau Aggregation Inhibitor Activity in a Tau-Transgenic Mouse Model, Current Alzheimer Research
  • 2020
    Cholinergic and inflammatory phenotypes in transgenic tau mouse models of Alzheimer’s Disease and Frontotemporal Lobar Degeneration, Brain Communications
  • 2016
    Soluble pre-fibrillar tau and β-amyloid species emerge in early human Alzheimer’s disease and track disease progression and cognitive decline, Acta Neuropathologica